ScholarIQanswers from OpenAlex

Treatment of advanced HER2-positive breast cancer: 2018 and beyond

PaperCitations, authors & open-access status

Treatment of advanced HER2-positive breast cancer: 2018 and beyond is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of advanced HER2-positive breast cancer: 2018 and beyond have?

ScholarIQcitation count

Treatment of advanced HER2-positive breast cancer: 2018 and beyond has 143 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of advanced HER2-positive breast cancer: 2018 and beyond published?

ScholarIQyear

Treatment of advanced HER2-positive breast cancer: 2018 and beyond has 2018 year in the ScholarIQ index.

What is the open-access status of Treatment of advanced HER2-positive breast cancer: 2018 and beyond?

ScholarIQoa status

Treatment of advanced HER2-positive breast cancer: 2018 and beyond has closed oa status in the ScholarIQ index.

What is the DOI of Treatment of advanced HER2-positive breast cancer: 2018 and beyond?

ScholarIQdoi

The DOI for Treatment of advanced HER2-positive breast cancer: 2018 and beyond is on the source record.

What is the PMID of Treatment of advanced HER2-positive breast cancer: 2018 and beyond?

ScholarIQpmid

The PMID for Treatment of advanced HER2-positive breast cancer: 2018 and beyond is on the source record.

What is the OpenAlex record for Treatment of advanced HER2-positive breast cancer: 2018 and beyond?

ScholarIQopenalex

The OpenAlex for Treatment of advanced HER2-positive breast cancer: 2018 and beyond is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial